Clinical Trial Update: Ibodutant for Relief of Irritable Bowel Syndrome With Diarrhoea (IBS-D) [Phase 2]

View source ↗

Summary

Phase 2 study of ibodutant for irritable bowel syndrome with diarrhea has completed, and results were posted in 2013. The sponsor/manufacturer is Menarini Group…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• ibodutant (ibodutant)

Snippet

Sponsor: Menarini Group | Conditions: Irritable Bowel Syndrome With Diarrhea | Phase 2 | Status: COMPLETED | Results posted: 2013-03-25